Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 752 Jan 1 – Oct 25, 2026
- Disclosed funding
- $25.9B 611 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| VT Develops next-generation therapies for migraine prevention | $46M | Series A | Healthtech, Biotech | United States | Investors | |
| SB Spot BiosystemsCompany profile Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines | $40M | Series B | Healthtech, Biotech | United States | Investors | |
| FH Fellow Health PartnersCompany profile Provides revenue cycle management services including billing, coding, and credentialing to physician groups and surgery centers Provides revenue cycle management services including billing, coding, and credentialing to physician groups and surgery centers | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
 AIRS MedicalCompany profile AIRS Medical develops MRI software that helps imaging providers increase scanner capacity and connect image acquisition with interpretation. AIRS Medical develops MRI software that helps imaging providers increase scanner capacity and connect image acquisition with interpretation. | Undisclosed | StrategicUndisclosed | Healthtech | South Korea | Investors | |
| K KimbaCompany profile Develops a scent-delivery system that adapts using biometric feedback for sleep-related use. Develops a scent-delivery system that adapts using biometric feedback for sleep-related use. | $6.5M | Seed | Healthtech | United States | Investors | |
| E EmmecellCompany profile Develops magnetic cell delivery technologies for treating corneal and other ophthalmic diseases Develops magnetic cell delivery technologies for treating corneal and other ophthalmic diseases | Undisclosed | StrategicUndisclosed | Healthtech, Biotech | United States | Investors | |
| R RejoniCompany profile Develops a hydrogel system to treat uterine health conditions and prevent scarring Develops a hydrogel system to treat uterine health conditions and prevent scarring | $25M | Series A | Healthtech | United States | Investors | |
| D DioseveCompany profile Develops iPS cell-derived co-culture technology to improve oocyte maturation and reduce IVF treatment burden Develops iPS cell-derived co-culture technology to improve oocyte maturation and reduce IVF treatment burden | $7M | Series A+Series A | Healthtech, Biotech | Japan | Investors | |
| R RocapineCompany profile Builds wellness apps for women's health, habit-building, and breaking compulsive behaviors Builds wellness apps for women's health, habit-building, and breaking compulsive behaviors | $13M | Series A | Healthtech | France | Investors | |
| MM Maia Medical Billing CorpCompany profile Provides AI-powered medical coding and revenue cycle management for orthopaedic practices Provides AI-powered medical coding and revenue cycle management for orthopaedic practices | $1.2M | Seed | Healthtech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.